Recombinant MS4A1 (Ocrelizumab Biosimilar) antibody

Catalog No. ABIN7597864

The Humanized Chimeric anti-MS4A1 (Ocrelizumab Biosimilar) antibody has been validated for not_set. It is suitable to detect MS4A1 (Ocrelizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant MS4A1 (Ocrelizumab Biosimilar) antibody (ABIN7597864)

Target: MS4A1 (Ocrelizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This MS4A1 (Ocrelizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-MS4A1 (Ocrelizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Ocrelizumab Biosimilar Antibody

Specificity: B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 1, MS4A1, Leukocyte surface antigen Leu-16, B-lymphocyte antigen CD20, Bp35, CD20

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 4.13 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for MS4A1 (Ocrelizumab Biosimilar)

Target: MS4A1 (Ocrelizumab Biosimilar)

Alternative Name: Ocrelizumab Biosimilar

Target Type: Biosimilar

Background: B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 1, MS4A1, Leukocyte surface antigen Leu-16, B-lymphocyte antigen CD20, Bp35, CD20

UniProt: P11836

CAS-No: 637334-45-3